-- 
Israeli Stocks: D-Pharm, Perrigo, Ratio Oil, Teva Pharmaceutical

-- B y   R o n i t   G o o d m a n
-- 
2011-04-14T14:28:27Z

-- http://www.bloomberg.com/news/2011-04-14/israeli-stocks-d-pharm-perrigo-ratio-oil-teva-pharmaceutical.html
Israel ’s TA-25 Index retreated for
a third day, declining 0.3 percent to 1,326.19 at the 4:30 p.m.
close in  Tel Aviv , paring the gain for the week to 0.7 percent.  Investors traded about 1.48 billion shekels ($433 million)
in shares and convertible securities.  The following stocks rose or fell today. Symbols are in
parentheses.  D-Pharm Ltd. (DPRM)   climbed the most since Feb. 20,
advancing 4 percent to 19.48 shekels. The biopharmaceutical
company said its DP-b99 drug for ischemic stroke was put on
“fast-track” status by the U.S. Food and Drug Administration.  Perrigo Co. (PRGO)   gained for a fifth day, increasing
1.4 percent to 299.80 shekels as partner  Teva Pharmaceutical
Industries Ltd. (TEVA)   received final over-the-counter
approval to sell fexofenadine HCl, the generic equivalent of
Sanofi-Aventis’ allergy drug Allegra. Teva, which already had
prescription approval for the medication, added 1.1 percent to
170.40 shekels.  Separately, Teva said preliminary data from two studies
showed multiple sclerosis patient improvement with use of
Copaxone.  Ratio Oil Exploration 1992 LP (RATIL)   decreased to
the lowest since Nov. 14, falling 3.3 percent to 0.44 shekel.
The oil and gas explorer is considering raising funds to finance
search and development plans at assets in which it is a partner.  To contact the reporter on this story:
Ronit Goodman in Tel Aviv at 
 rgoodman9@bloomberg.net   To contact the editor responsible for this story:
Claudia Maedler at 
 cmaedler@bloomberg.net  